| __timestamp | Arrowhead Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 759285000 |
| Thursday, January 1, 2015 | 382000 | 862944000 |
| Friday, January 1, 2016 | 158333 | 950751000 |
| Sunday, January 1, 2017 | 31407709 | 879387000 |
| Monday, January 1, 2018 | 16142321 | 661913000 |
| Tuesday, January 1, 2019 | 168795577 | 669893000 |
| Wednesday, January 1, 2020 | 87992066 | 644769000 |
| Friday, January 1, 2021 | 138287000 | 548970000 |
| Saturday, January 1, 2022 | 243231000 | 561347000 |
| Sunday, January 1, 2023 | 240735000 | 572952000 |
| Monday, January 1, 2024 | 3551000 | 629182000 |
Cracking the code
In the ever-evolving pharmaceutical industry, Arrowhead Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have showcased contrasting revenue trajectories over the past decade. From 2014 to 2024, Taro consistently outperformed Arrowhead, with revenues peaking at approximately $950 million in 2016. Despite a slight decline, Taro maintained a robust average annual revenue of around $700 million. In contrast, Arrowhead's revenue journey was more volatile, starting at a modest $175,000 in 2014 and reaching a high of $243 million in 2022. This represents a staggering growth of over 138,000% for Arrowhead, highlighting its dynamic expansion strategy. As of 2024, Taro's revenue stands at $629 million, while Arrowhead's is at $3.55 million, indicating a potential shift in market dynamics. This data underscores the competitive landscape and strategic maneuvers within the pharmaceutical sector.
Johnson & Johnson and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
GSK plc vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Biogen Inc. and Arrowhead Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: Incyte Corporation vs Arrowhead Pharmaceuticals, Inc.
Who Generates More Revenue? Incyte Corporation or Taro Pharmaceutical Industries Ltd.
Annual Revenue Comparison: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.
Annual Revenue Comparison: Merus N.V. vs Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs MiMedx Group, Inc.: Examining Key Revenue Metrics
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd. or Celldex Therapeutics, Inc.: Who Leads in Yearly Revenue?
Breaking Down Revenue Trends: Taro Pharmaceutical Industries Ltd. vs BioCryst Pharmaceuticals, Inc.